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Background: Atrial fibrillation (AF) is a life-threatening arrhythmia that carries the high risk of thromboembolic
complication. Stroke often develops in patients who undergo successful Cox Maze procedure, despite the fact that
the procedure has shown a high rate of success in sinus conversion from AF. This study examined the preoperative
risk factors predictive of stroke following Cox Maze procedure in patients with mitral valve disease.
Methods: 240 patients with the mean age of 57 years underwent Cox-Maze IV procedure with mitral valve repair
from November 2007 through December 2010. All patients were available during the follow-up period with the
mean duration of 23.6 months. This study excluded those patients who had undergone mitral valve replacement
because of maintenance of warfarin medication
Results: Sixteen patients had an ischemic stroke. Of these sixteen patients, six had a transitional ischemic accident
while the remaining ten had cerebral infarction. Twelve of sixteen showed sustained sinus rhythm, three showed
AF and one had pacing rhythm. Univariate analysis showed that only preoperative stroke history was associated
with postoperative stroke (p = 0.03). High CHA2DS2-VASc score, rheumatic etiology, large left atrium (LA),
preoperative or postoperative LA thrombus, age, sex, hypertension, and concomitant surgery were not associated
with predictive risks for stroke.
Conclusions: In the group of patients who underwent the Cox-Maze procedure with mitral valve repair, having a
stroke history was the only preoperative risk factor that could lead to a stroke event after surgery. Accordingly,
patients with affliction of ischemic stroke, albeit sustained sinus rhythm, may require prophylactic anticoagulation.
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Atrial fibrillation (AF) is the most significant arrhythmia
that may cause thromboembolic complications. AF under
any circumstance causes reduction of cardiac output and
thrombus formation that may provide the grounds for sys-
temic embolism. AF increases the risk of death by nearly
twice and ischemic stroke by about five folds [1]. In par-
ticular, AF occurs in 30~50% from the group of patients
with mitral valve disease [2,3]. With respect to the reason
for a hospital visit in these patients, there are more cases
with symptoms associated with stroke than there are cases* Correspondence: jwchungcs@gmail.com
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unless otherwise stated.with symptoms related to cardiac disease. AF would not
largely disappear by surgical modality with mitral valve
repair alone in such group of patients.
Advances in the Cox-Maze procedure have made it
the most valid method in AF treatment. Its complex
techniques have continuously been modified and advanced
[4] to the point of achieving 90% success rate in sur-
gery [5-7].
The success rate of having sinus conversion of the
heart rhythm after Cox-Maze procedure is considerable
in patients with a mitral valve disease. Nevertheless,
ischemic stroke occurs quite often in patients with success-
ful sinus conversion. The reason may be that patients have
either transient reversion to AF or a cerebral arterial dis-
ease. However, a recent study revealed that the incidence. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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large left atrium devoid of contractile function in the left
atrium [8].
This study examined the incidence rate of stroke
following mitral valve surgery and Cox-Maze procedure
in AF patients with mitral valve disease. This study re-
trospectively analyzed various preoperative parameters




This study included 240 patients who had been diagnosed
as having mitral valve disease and AF from November 2007
through December 2010. The mean age was 56.9 years and
the male proportion was 38.0%. Demographic data was
summarized in Table 1. All of these patients underwent
Cox Maze procedure and mitral valve repair. Because of
continuous postsurgical warfarin administration for antic-
oagulation therapy, those patients who had undergoneTable 1 Demographic data and operative profiles
Number of patients 240
Age, years 56.9 ± 12.1
M/F, n 91/149
HTN, n (%) 39 (16.3)
History of preoperative stroke 28 (11.7)
Prior cardiac surgery, n (%) 8 (3.3)
AF type
Paroxysmal, n (%) 5 (2.1)
Persistent, n (%) 235 (97.9)
Mitral diagnosis
Rheumatic, n (%) 139 (57.9)
Degenerative, n (%) 94 (39.2)
Others, n (%) 7 (2.9)
Presence of left atrial thrombus, n (%) 22 (9.2)
Echocardiographic data
LV EF,% 59.7 ± 7.4
LA dimension, mm 51.0 ± 11.7
MV operation
MV repair, n (%) 240 (100)
Concomitant cardiac surgery
AV repair, n (%) 80 (33.3)
TV repair, n (%) 64 (26.7)
CABG, n (%) 8 (3.3)
ASD or PFO closure, n (%) 9 (3.8)
Other, n (%) 3 (1.3)
Abbreviations: HTN, hypertension; AF, atrial fibrillation; LV, left ventricle; EF,
ejection fraction; LA, left atrium; MV mitral valve; AV, aortic valve; TV, tricuspid
valve; CABG, coronary artery bypass graft; ASD, atrial septal defect; PFO, patent
foramen ovale.mitral valve replacement were excluded. AF was confir-
med in the 12-lead electrocardiogram performed for all
patients within a week prior to surgery. All data of medical
records, clinical history, electrocardiogram and echocardi-
ography were retrospectively collected after surgery, and
the data were accounted for all patients while follow-up
observations were attainable for all patients. The Guide-
lines for Reporting Data and Outcomes for the Surgical
Treatment of Atrial Fibrillation [9] were used for the def-
inition of AF recurrence, data analysis and comparison.
The Institutional Review Board at Konkuk University
Medical Center approved this study (No. KUH1080013).
Cryothermy procedure
The cryothermy procedure was carried out by using the
modified left-sided Cox Maze IV procedure [10]. Figure 1
shows our procedure sets. After left atriotomy, separate
two box lesions for pulmonary isolation were made with
extended left atriotomy incision. Then, the lines between
two box lesions were ablated. A line form the pulmonary
isolation lesion to left atrial appendage and another line
from the pulmonary isolation lesion to mitral valve annu-
lus were made. Left atrial appendage isolation was done.
With respect to deployment of cryothermy energy, cyroa-
blation using the argon gas-based device (Medtronic Co.
USA) set at −180°C was performed for one minute to
obtain transmural lesion. Left atrial appendage was neither
ligated nor resected.
Surgical procedure
All surgeries were carried out under cardiopulmonary
bypass after reaching moderate hypothermia and cardio-
plegia-induced cardiac arrest by infusing a cardioplegic
solution. An antegrade approach was only used for car-
dioplegic solution in isolated mitral valve surgery, while
a retrograde approach was used in mitral valve surgeryFigure 1 Diagram of the left atrial Cox-Maze procedure using
cryothermy energy (black dotted lines).
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cardioplegic solution was infused every 35 minutes. Intra-
operative transesophageal echocardiogram was inserted
for all patients. The mitral valve was exposed by making
incision on the interatrial groove for all patients, and
cryothermy ablation was performed using the left-sided
Cox-Maze IV procedure (Figure 1). In cases of mitral
regurgitation, patch obliteration technique [11] for
posterior leaflet prolapsed and artificial chordae for-
mation techniques for anterior leaflet prolapse were
employed. Annuloplasty was performed by using the
Mitra-strip (ScienCity, Inc. Seoul, Korea), which had been
newly developed for the posterior supraannular plica-
tion [12].
For the repair of rheumatic mitral disease, in which
mitral stenosis due to leaflet calcification would be the
primary lesion, 1) thickened calcified leaflet was removed
by slicing, then, 2) commissurotomy was performed, fol-
lowed by 3) making extension of the posterior leaflet by
using a bovine pericardial patch, and then 4) annuloplasty
incorporating the Mitra-strip was carried out.
The concomitant procedures included tricuspid valve
repair, aortic valve repair, coronary artery bypass grafting,
ASD closure or others.
Postoperative management
Overall postoperative care was similar to that of patients
with routine cardiac surgery. Amiodarone was infused to
all patients except for patients who developed bradycardia
(pulse rate < 60beats/min). A saturation dose of 300 mg
adiodarone was slowly injected after surgery. Thereafter,
an oral dose of 200 ~ 400 mg/day was administered after
extubation. Amiodarone was prescribed for all other pa-
tients who did not develop bradycardia during the hospital
day, and was maintained for three months after discharge
from our institute. Anticoagulation therapy was also
maintained for three months after discharge in patient
with successful Cox-Maze procedure due to the applica-
tion of annuloplasty ring. After discharge, all patients were
followed-up at the outpatient clinic once every three
months on the average. On each visit at the outpatient
clinic, patients underwent 12-lead ECG for check-up.
Amiodarone and anticoagulation were continued for pa-
tients with AF recurrence after hospital discharge. When
patients developed stroke, anticoagulation therapy along
with neurology consultation was immediately started
again, albeit no recurrence of AF.
Statistical analysis
Continuous variables were expressed as the mean and
standard deviation while discrete variables were expressed
in frequency and percentage. The Cox proportional haz-
ards regression model as well as univariate analyses were
used to determine the risk factors. SPSS Korean version18.0 (SPSS Inc, Chicago, IL USA) was used for the statis-
tical process and the p values less than 0.05 were consid-
ered statistically significant.
Results
The characteristics of the patients
Of these two 240 patients who underwent the left-sided
Cox Maze IV procedure with mitral valve repair, 91 were
males, 39 had hypertension and 28 had a history of
thromboembolic event before surgery. Eight patients had
a history of prior heart surgery. Permanent AF type was
overwhelmingly numerous with the number of patients
showing 235 (97.9%). Preoperative echocardiography
confirmed the left atrial enlargement suggestive of a mitral
valve disease in the most patients. 22 patients (9.2%) were
confirmed as having a thrombus in the left atrium during
surgery (Table 1).
The primary indications for surgery and pathologic
findings revealed that 94 patients had degenerative mi-
tral valve regurgitation while 139 patients had a rheum-
atic disease with the evidence of mitral valve stenosis
with insufficiency (Table 1).
All of 240 patients underwent mitral valve repair with
Cox-Maze procedure. The most frequently performed
concomitant surgery was aortic valve repair (80 cases).
This was followed by 64 cases of tricuspid valve repair,
eight cases of coronary artery bypass grafting and nine
cases of either atrial septal defect or persistent foramen
ovale closure (Table 1).
Clinical outcomes
All of 240 patients who underwent the left-sided
Cox-Maze procedure with mitral valve repair were
followed-up for the mean duration of 23.6 ± 7.9 months.
Among these 240, sixteen subjects (6.7%) developed
thromboembolic event(s) during the follow-up period. Of
these sixteen patients, six suffered with mild transitional
ischemic accident (TIA) but recovered symptomatically
within a day. The rest of the patients were diagnosed
as having cerebral infarction by neurologists as well as
brain computed tomographic scan confirmation. Eight
patients fully recovered with anticoagulation and rehabili-
tative treatment. One patient recuperated after right mid-
dle cerebral artery thrombectomy while the remaining
one patient expired from pneumonia during the neuro-
logic treatment after development of stroke. All sixteen
patients were treated in the hospital at the time of
thromboembolic event, and left atrial thrombus was not
found for all of them in echocardiography which was per-
formed on admission.
The time it took to development of thromboembolic
event after surgery was 227.6 ± 333.6 days on the average.
The ECG results of sixteen patients on admission showed
that sinus rhythm was found in twelve patients (75%), AF
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patient (6.3%).
Predictive risk factors of thromboembolic events after
Cox-Maze procedure
We analyzed risk factors among various preoperative
variables such as age, sex, rheumatic etiology of mitral
valve disease, preoperative left atrial size, history of prior
cardiac surgery, hypertension, presence of left atrial
thrombus, concomitant cardiac surgery and history of
thromboembolic events, which could affect throm-
boembolic events after surgery (Table 2). Univariate
analysis showed that the history of thromboembolic event
was significantly related to the postoperative stroke (odds
ratio [OR] 3.23, 95% confidential interval [CI] 1.12-9.26,
p = 0.03). Patients with CHADs2-VAS score ≥2 had a
tendency to have postoperative stroke, but it did not
reach statistical significance (OR 2.60, 95% CI 0.90-7.48,
p = 0.08). Other parameters that listed above revealed
not related with postoperative stroke (Table 2).
Discussion
The present study showed that preoperative history of
stroke would increase the risk of postoperative stroke
after Cox-Maze procedure with mitral valve repair. Buber
et al. suggested left atrial mechanical contraction and left
atrial size as the postoperative risks of stroke after Cox-
Maze procedure [8]. However, there were few studies that
analyze the risk factors for postoperative stoke. Many
studies focused on the factors influencing the outcome of
Cox-Maze procedure itself [13-17], but few studies fo-
cused on postoperative stroke [8]. Owing to the fact that
AF increases stroke incidence by five folds [1], previousTable 2 Preoperative risk factors of thromboembolic
events
Univariate
OR (95% CI) p value
Age, years 1.34 (0.19-10.52) 0.75
Sex 0.92 (0.34-2.48) 0.86
Rheumatic etiology 0.63 (0.24-1.63) 0.34
Preoperative giant LA (>60 mm) 0.65 (0.15-2.87) 0.57
Hypertension 0.34 (0.05-2.58) 0.30
Concomitant cardiac surgery 1.08 (0.41-2.84) 0.88
Warfarin stop at 3 M postoperatively 0.79 (0.30-2.08) 0.63
Preoperative anticoagulation NA
Preoperative LA thrombus 0.65 (0.09-.4.89) 0.67
Postoperative LA thrombus 2.25 (0.51-9.93) 0.28
Preoperative stroke history 3.23 (1.12-9.26) 0.03
CHADs2-VAS score 2.60 (0.90-7.48) 0.08
Abbreviations: LA, left atrium; M, month; OR, odds ratio; CI, confidential interval;
NA, not applicable due to zero count.studies have focused on either restoring sinus rhythm or
analysis of the risk factors that lead to failure of Cox-Maze
procedure. Furthermore, the incidence of postoperative
stroke is a mere 1-3% [13,18,19], making it difficult to
analyze the risk factors of postoperative stroke. On the
other hand, having the incidence rate of postoperative
stroke of 6.7% in this study is considerably higher than
that of other previous studies. However, heterogeneous
population, witnessed in this investigation, involving a
large numbers of rheumatic mitral valve and double valve
diseases, may affect the incidence rate of stroke. It was
remarkable that twelve of sixteen patients (75%) with post-
operative stroke demonstrated sinus rhythm while eight of
the twelve (67%) patients had left atrial mechanical con-
traction in echocardiography at the onset of stroke. This
result did not concur with that of Buber et al. study [8].
Buber et al. reported fifteen cases of stroke (10% in
patients with normal sinus rhythm or 6.4% of the entire
Cohort) in patients with sinus rhythm following successful
Cox-Maze procedure, and also demonstrated that restor-
ation of sinus rhythm would not enough to avoid the
stroke [8]. Furthermore, they concluded that the absence
of left atrial mechanical contraction would be a strong
independent risk factor for the postoperative stroke. The
consideration is that a history of preoperative stroke is
closely related with postoperative stroke regardless of left
atrial mechanical contraction, albeit only univariate
analysis which had been carried out. Meanwhile, the
CHA2DS2-VASc score for stroke prediction [20] was ana-
lyzed as a risk factor. Univariate analysis showed that high
CHA2DS2-VASc score (score ≥2) appeared not to be
related with postoperative stroke (p = 0.08). This was
consistent with the result of Buber and colleague [8]. This
outcome was unexpected due to the fact that stroke risk
score took account of history of stroke, transient ischemic
attack and thromboembolism, which would be considered
high risk in these cases. Such finding might have resulted
from the aspect that the CHA2DS2-VASc score consisted
of the combination of several risk factors.
In this study, all patients underwent left atrial ablation
with cryoablation system. Left atrial ablation has the
benefits of less procedure time, less procedure extent
and less incidence of bradyarrhythmias. The left atrial
ablation would be a more appropriated procedure than
biatrial ablation with respect to a minimally invasive
technique [21,22]. Based on the fact that it is the proced-
ure for patients with a mitral valve disease in which AF
developed in the posterior wall of the left atrium and the
periphery of pulmonary veins, it was judged that suffi-
cient efficacy could be attained with the left-sided Cox
Maze IV procedure. Only the left-sided procedure was
carried out on the notion that, since the procedure could
be performed in merely about 10 minutes, there would
be no effect on morbidity or mortality by the surgery,
Table 3 Postoperative rhythm status
NSR AF or A flat Junctional rhythm Pacing rhythm
3 months 71.1% 25.1% 2.1% 1.7%
6 months 70.9% 25.6% 1.7% 1.7%
1 year 73.4% 22.7% 2.1% 1.7%
2 years 72.2% 23.9% 1.7% 2.2%
Abbreviations: NSR, normal sinus rhythm; AF, atrial fibrillation; A flat, atrial flatter.
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results coming out of this procedure [10,21]. This study
revealed that overall success rate of Cox-Maze proced-
ure was about 70% (Table 3). This was comparable to
that of previous report in which patient underwent left-
sided maze procedure with mitral valve surgery [21].
However this rate was lower than the biatrial maze with
its rate showing 90% [5-7]. Compared with biatrial abla-
tion, more frequent recurrence of atrial fibrillation in
patients with mitral valve surgery [18] were evident in
left atrial ablation. In this study, 139 patients (58%) had
rheumatic mitral valve disease and 80 patients (33%)
underwent concomitant aortic valve surgery. Previous
studies demonstrated that patients with a rheumatic
mitral valve disease and a multiple valvular disease have
worse outcomes [16,21,23]. These reports supported the
low success rate of the maze procedure among these
patients with a valvular ailment.
This study had a number of limitations. Having con-
ducted a retrospective study with observational data,
albeit all subjects were followed up for observations,
these subjects were not homogenous and follow-up dur-
ation was relatively short. Only 142 of 240 patients
underwent isolated mitral valve surgery including mitral
valve repair, repair of function tricuspid regurgitation as
well as Cox-Maze procedure, and others had surgery of
double valve diseases or of the concomitant coronary
artery surgery. This might have affected the success rate
of the Cox-Maze procedure and the incidence rate of
the stroke. A long-term study is necessary to confirm
the results of this investigation. The results of this study
were reported with rhythm statuses at intervals, and this
might have overestimated the success rate of the Cox-
Maze procedure [17]. A large scaled multi-center study is
needed to overcome several limitations of which limited
sample size and a single-center study.
Conclusions
A history of preoperative stroke would increase the post-
operative risk of stroke, following the Cox-Maze proced-
ure concomitantly with mitral valve repair, in the group of
patients with permanent AF accompanied by a structural
mitral valve disease. Therefore, patients who had experi-
enced ischemic strokes might require preventive anticoa-
gulation even in cases with sustained sinus rhythm.Competing interests
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